ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Jennifer Brooke Goldstein
Matched on ORCID iD 0000-0002-0577-7746; OpenAlex author ID A5044662625. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 34
2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- Outcomes of Irreversible Electroporation for Treatment of Refractory Locally Advanced Pancreatic Cancer. Co-author DOI 10.1016/j.jvir.2026.108954↗
- Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-19-0224↗
- High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. Co-author DOI 10.1158/1940-6207.capr-18-0014↗
- Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy. First author DOI 10.1097/mpa.0000000000000914↗
- Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience. Co-author DOI 10.18632/oncotarget.19897↗
Closest collaborators
The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nadine Abi‐Jaoudeh · 1 shared paper, 2026 · strength 0.29
- Farshid Dayyani · 1 shared paper, 2026 · strength 0.29
- David K. Imagawa · 1 shared paper, 2026 · strength 0.29
- Fa-Chyi Lee · 1 shared paper, 2026 · strength 0.29
- Ricardo Azevedo · 1 shared paper, 2026 · strength 0.29
- Gauri Rajani Varadhachary · 4 shared papers, 2017–2020 · strength 0.28
- Paper Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic … DOI 10.1158/1078-0432.ccr-19-0224↗
- Paper High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. DOI 10.1158/1940-6207.capr-18-0014↗
- Paper Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated Wit… DOI 10.1097/mpa.0000000000000914↗
- David R. Fogelman · 3 shared papers, 2017–2020 · strength 0.22
- Paper Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic … DOI 10.1158/1078-0432.ccr-19-0224↗
- Paper High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. DOI 10.1158/1940-6207.capr-18-0014↗
- Paper Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Cent… DOI 10.18632/oncotarget.19897↗
- Robert A. Wolff · 3 shared papers, 2017–2020 · strength 0.21
- Paper Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic … DOI 10.1158/1078-0432.ccr-19-0224↗
- Paper Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated Wit… DOI 10.1097/mpa.0000000000000914↗
- Paper Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Cent… DOI 10.18632/oncotarget.19897↗
- Phillip Andrew Futreal · 2 shared papers, 2018–2020 · strength 0.17
- Paper Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic … DOI 10.1158/1078-0432.ccr-19-0224↗
- Paper High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. DOI 10.1158/1940-6207.capr-18-0014↗
- Florencia M. McAllister · 2 shared papers, 2018–2020 · strength 0.17
- Paper Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic … DOI 10.1158/1078-0432.ccr-19-0224↗
- Paper High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. DOI 10.1158/1940-6207.capr-18-0014↗
- Milind M. Javle · 2 shared papers, 2017–2020 · strength 0.16
- Paper Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic … DOI 10.1158/1078-0432.ccr-19-0224↗
- Paper Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Cent… DOI 10.18632/oncotarget.19897↗
- Matthew H. G. Katz · 2 shared papers, 2017–2018 · strength 0.12
- Paper High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. DOI 10.1158/1940-6207.capr-18-0014↗
- Paper Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated Wit… DOI 10.1097/mpa.0000000000000914↗
- Anirban Maitra · 2 shared papers, 2017–2018 · strength 0.12
- Paper High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. DOI 10.1158/1940-6207.capr-18-0014↗
- Paper Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated Wit… DOI 10.1097/mpa.0000000000000914↗
- Michael James Overman · 1 shared paper, 2020 · strength 0.10
- Rachna T. Shroff · 1 shared paper, 2020 · strength 0.10
- Sarah A. Bannon · 1 shared paper, 2018 · strength 0.07
- Maureen E. Mork · 1 shared paper, 2018 · strength 0.07
- Ignacio Ivan Wistuba · 1 shared paper, 2017 · strength 0.06
- Huamin Wang · 1 shared paper, 2017 · strength 0.06
- Reza Nejati · 1 shared paper, 2017 · strength 0.06
- Hua Wang · 1 shared paper, 2017 · strength 0.06
- Jorge M. Blando · 1 shared paper, 2017 · strength 0.06
- Daniel M. Halperin · 1 shared paper, 2017 · strength 0.06
- Jason B. Fleming · 1 shared paper, 2017 · strength 0.06
- Jeffrey E. Lee · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.